标题
Trial Watch: Radioimmunotherapy for oncological indications
作者
关键词
-
出版物
OncoImmunology
Volume 3, Issue 9, Pages e954929
出版商
Informa UK Limited
发表日期
2014-10-30
DOI
10.4161/21624011.2014.954929
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- p53, ROS and senescence in the control of aging
- (2016) Arnaud Vigneron et al. Aging-US
- TP53 and MTOR crosstalk to regulate cellular senescence
- (2016) Lorenzo Galluzzi et al. Aging-US
- Myeloablative Anti-CD20 Radioimmunotherapy +/- High-Dose Chemotherapy Followed by Autologous Stem Cell Support for Relapsed/Refractory B-Cell Lymphoma Results in Excellent Long-Term Survival
- (2015) Julia Y. Wagner et al. Oncotarget
- Toll-like receptor-5 agonist Entolimod broadens the therapeutic window of 5-fluorouracil by reducing its toxicity to normal tissues in mice
- (2015) Bojidar M. Kojouharov et al. Oncotarget
- Immunochemoradiotherapy for Patients with Oral Squamous Cell Carcinoma: Augmentation of OK-432-Induced Helper T Cell 1 Response by 5-FU and X-ray Irradiation
- (2015) Tomoyuki Tano et al. NEOPLASIA
- Prognostic and Predictive Values of the Immunoscore in Patients with Rectal Cancer
- (2014) M.-G. Anitei et al. CLINICAL CANCER RESEARCH
- Effect of preoperative chemoradiotherapy on outcome of patients with locally advanced esophagogastric junction adenocarcinoma—a pilot study
- (2014) M. Orditura et al. Current Oncology
- Impact of myeloid cells on the efficacy of anticancer chemotherapy
- (2014) Laura Senovilla et al. CURRENT OPINION IN IMMUNOLOGY
- RAS mutations and cetuximab in locally advanced rectal cancer: Results of the EXPERT-C trial
- (2014) F. Sclafani et al. EUROPEAN JOURNAL OF CANCER
- The combination of a chemotherapy doublet (gemcitabine and capecitabine) with a biological doublet (bevacizumab and erlotinib) in patients with advanced pancreatic adenocarcinoma. The results of a phase I/II study
- (2014) D.J. Watkins et al. EUROPEAN JOURNAL OF CANCER
- Feasibility of preoperative and postoperative chemoradiotherapy in gastric adenocarcinoma. Two phase II studies done in parallel. Fédération Francophone de Cancérologie Digestive 0308
- (2014) Pierre Michel et al. EUROPEAN JOURNAL OF CANCER
- Phase 2 Trial of Induction Gemcitabine, Oxaliplatin, and Cetuximab Followed by Selective Capecitabine-Based Chemoradiation in Patients With Borderline Resectable or Unresectable Locally Advanced Pancreatic Cancer
- (2014) Nestor F. Esnaola et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Five Fractions of Radiation Therapy Followed by 4 Cycles of FOLFOX Chemotherapy as Preoperative Treatment for Rectal Cancer
- (2014) Robert J. Myerson et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Chemoradiation of Hepatic Malignancies: Prospective, Phase 1 Study of Full-Dose Capecitabine With Escalating Doses of Yttrium-90 Radioembolization
- (2014) Ryan Hickey et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Concurrent Chemoradiotherapy with Docetaxel, Cisplatin and 5-Fluorouracil (TPF) in Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck
- (2014) Masanori Komatsu et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Irradiation and anti–PD-L1 treatment synergistically promote antitumor immunity in mice
- (2014) Liufu Deng et al. JOURNAL OF CLINICAL INVESTIGATION
- Role of Radiotherapy to Bulky Disease in Elderly Patients With Aggressive B-Cell Lymphoma
- (2014) Gerhard Held et al. JOURNAL OF CLINICAL ONCOLOGY
- Neoadjuvant Chemotherapy Without Routine Use of Radiation Therapy for Patients With Locally Advanced Rectal Cancer: A Pilot Trial
- (2014) Deborah Schrag et al. JOURNAL OF CLINICAL ONCOLOGY
- Patterns of Recurrence After Surgery Alone Versus Preoperative Chemoradiotherapy and Surgery in the CROSS Trials
- (2014) Vera Oppedijk et al. JOURNAL OF CLINICAL ONCOLOGY
- Flagellin Treatment Protects against Chemicals, Bacteria, Viruses, and Radiation
- (2014) M. Vijay-Kumar et al. JOURNAL OF IMMUNOLOGY
- Targeted Chemoradiation in Metastatic Colorectal Cancer: A Phase I Trial of 131I-huA33 with Concurrent Capecitabine
- (2014) R. A. Herbertson et al. JOURNAL OF NUCLEAR MEDICINE
- Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5/ACCORD17): final results of a randomised, phase 2/3 trial
- (2014) Thierry Conroy et al. LANCET ONCOLOGY
- Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study
- (2014) Jean-François Bosset et al. LANCET ONCOLOGY
- Regulated necrosis: the expanding network of non-apoptotic cell death pathways
- (2014) Tom Vanden Berghe et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
- (2014) Mark R. Gilbert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
- (2014) Olivier L. Chinot et al. NEW ENGLAND JOURNAL OF MEDICINE
- Necroptosis
- (2014) Andreas Linkermann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Molecular mechanisms of regulated necrosis
- (2014) Lorenzo Galluzzi et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Concomitant chemoradiotherapy versus induction chemotherapy followed by chemoradiotherapy as definitive, first line treatment of squamous cell carcinoma of the head and neck
- (2014) P. Balermpas et al. STRAHLENTHERAPIE UND ONKOLOGIE
- Oxaliplatin and capecitabine concomitant with neoadjuvant radiotherapy and extended to the resting period in high risk locally advanced rectal cancer
- (2014) Y.-H. Gao et al. STRAHLENTHERAPIE UND ONKOLOGIE
- Radiotherapy for patients with isolated local recurrence of primary resected pancreatic cancer
- (2014) Akira Nakamura et al. STRAHLENTHERAPIE UND ONKOLOGIE
- Long-term Complete Remission Following Radiosurgery and Immunotherapy in a Melanoma Patient with Brain Metastasis: Immunologic Correlates
- (2014) J. Karbach et al. Cancer Immunology Research
- Trial Watch
- (2014) Fernando Aranda et al. OncoImmunology
- Immunosuppressants in cancer prevention and therapy
- (2014) Mikhail V Blagosklonny OncoImmunology
- Anti-PD-1 antibodies for the treatment of B-cell lymphoma
- (2014) Fuliang Chu et al. OncoImmunology
- Trial Watch
- (2014) Jonathan Pol et al. OncoImmunology
- Trial Watch
- (2014) Fernando Aranda et al. OncoImmunology
- Trial Watch
- (2014) Fernando Aranda et al. OncoImmunology
- Trial watch
- (2014) Erika Vacchelli et al. OncoImmunology
- Two is better than one: Complementing oncolytic virotherapy with gemcitabine to potentiate antitumor immune responses
- (2014) Shashi Gujar et al. OncoImmunology
- Is tumor (R)ejection by the immune system the “5th R” of radiobiology?
- (2014) Encouse Golden et al. OncoImmunology
- Prognostic Significance of Pretreatment 18F-FDG PET/CT in Patients with Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma Treated by Radioimmunotherapy Using 131I-Rituximab
- (2013) Ilhan Lim et al. ACTA HAEMATOLOGICA
- A phase I trial of immunostimulatory CpG 7909 oligodeoxynucleotide and90yttrium ibritumomab tiuxetan radioimmunotherapy for relapsed B-cell non-Hodgkin lymphoma
- (2013) Thomas E. Witzig et al. AMERICAN JOURNAL OF HEMATOLOGY
- Ipilimumab alone or in combination with radiotherapy in metastatic castration-resistant prostate cancer: results from an open-label, multicenter phase I/II study
- (2013) S. F. Slovin et al. ANNALS OF ONCOLOGY
- Palliative radiotherapy and chemotherapy instead of surgery in symptomatic rectal cancer with synchronous unresectable metastases: a phase II study
- (2013) D. Tyc-Szczepaniak et al. ANNALS OF ONCOLOGY
- Unexpected toxicity of cetuximab combined with conventional chemoradiotherapy in patients with locally advanced anal cancer: results of the UNICANCER ACCORD 16 phase II trial†
- (2013) E. Deutsch et al. ANNALS OF ONCOLOGY
- Evaluation of short-course radiotherapy followed by neoadjuvant bevacizumab, capecitabine, and oxaliplatin and subsequent radical surgical treatment in primary stage IV rectal cancer†
- (2013) T. H. van Dijk et al. ANNALS OF ONCOLOGY
- A phase II randomized trial of induction chemotherapy versus no induction chemotherapy followed by preoperative chemoradiation in patients with esophageal cancer
- (2013) J. A. Ajani et al. ANNALS OF ONCOLOGY
- Long-term follow-up of a phase III study comparing radiotherapy with or without weekly oxaliplatin for locoregionally advanced nasopharyngeal carcinoma
- (2013) X. Wu et al. ANNALS OF ONCOLOGY
- Phase II Study of Induction Fixed-Dose Rate Gemcitabine and Bevacizumab Followed by 30 Gy Radiotherapy as Preoperative Treatment for Potentially Resectable Pancreatic Adenocarcinoma
- (2013) George Van Buren et al. ANNALS OF SURGICAL ONCOLOGY
- Comparison of “sandwich chemo-radiotherapy” and six cycles of chemotherapy followed by adjuvant radiotherapy in patients with stage IIIC endometrial cancer: a single center experience
- (2013) Nasuh Utku Dogan et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Toll-like Receptor 5 Agonism Protects Mice from Radiation Pneumonitis and Pulmonary Fibrosis
- (2013) Zhi-Dong Wang et al. Asian Pacific Journal of Cancer Prevention
- Low Annexin A1 expression predicts benefit from induction chemotherapy in oral cancer patients with moderate or poor pathologic differentiation grade
- (2013) Dong-wang Zhu et al. BMC CANCER
- Differentiation of irradiation and cetuximab induced skin reactions in patients with locally advanced head and neck cancer undergoing radioimmunotherapy: the HICARE protocol (Head and neck cancer: ImmunoChemo and Radiotherapy with Erbitux) – a multicenter phase IV trial
- (2013) G Habl et al. BMC CANCER
- Radiotherapy plus nimotuzumab or placebo in the treatment of high grade glioma patients: results from a randomized, double blind trial
- (2013) Maria Teresa Solomón et al. BMC CANCER
- Intensity-modulated radiotherapy with simultaneous modulated accelerated boost technique and chemotherapy in patients with nasopharyngeal carcinoma
- (2013) Muhammad M Fareed et al. BMC CANCER
- Short-course radiotherapy followed by neo-adjuvant chemotherapy in locally advanced rectal cancer – the RAPIDO trial
- (2013) Per J Nilsson et al. BMC CANCER
- Cetuximab and platinum-based chemoradio- or chemotherapy of patients with epidermal growth factor receptor expressing adenoid cystic carcinoma: a phase II trial
- (2013) E Hitre et al. BRITISH JOURNAL OF CANCER
- Development of an imaging-guided CEA-pretargeted radionuclide treatment of advanced colorectal cancer: first clinical results
- (2013) R Schoffelen et al. BRITISH JOURNAL OF CANCER
- A phase II study of weekly neoadjuvant chemotherapy followed by radical chemoradiation for locally advanced cervical cancer
- (2013) M McCormack et al. BRITISH JOURNAL OF CANCER
- A multi-institutional phase 2 study of neoadjuvant gemcitabine and oxaliplatin with radiation therapy in patients with pancreatic cancer
- (2013) Edward J. Kim et al. CANCER
- Neoadjuvant chemotherapy followed by concurrent chemoradiation for locoregionally advanced nasopharyngeal carcinoma
- (2013) Lin Kong et al. CANCER
- Phase 1 study of cetuximab in combination with 5-fluorouracil, cisplatin, and radiotherapy in patients with locally advanced anal canal carcinoma
- (2013) Luis O. Olivatto et al. CANCER
- Progress report of a randomized trial comparing long-term survival and late toxicity of concurrent chemoradiotherapy with adjuvant chemotherapy versus radiotherapy alone in patients with stage III to IVB nasopharyngeal carcinoma from endemic regions of Ch
- (2013) Yong Chen et al. CANCER
- Phase I Study of a Modified Regimen of 90Yttrium–Ibritumomab Tiuxetan for Relapsed or Refractory Follicular or Transformed CD20+ Non-Hodgkin Lymphoma
- (2013) Christos Vaklavas et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Low-Dose Irradiation Programs Macrophage Differentiation to an iNOS+/M1 Phenotype that Orchestrates Effective T Cell Immunotherapy
- (2013) Felix Klug et al. CANCER CELL
- Phase II study of concurrent thoracic radiotherapy in combination with weekly paclitaxel plus carboplatin in locally advanced non-small cell lung cancer: LOGIK0401
- (2013) Koichi Takayama et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Phase II trial of neoadjuvant docetaxel and cisplatin followed by intensity-modulated radiotherapy with concurrent cisplatin in locally advanced nasopharyngeal carcinoma
- (2013) Ya Hua Zhong et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Toxicity study of gemcitabine, oxaliplatin, and bevacizumab, followed by 5-fluorouracil, oxaliplatin, bevacizumab, and radiotherapy, in patients with locally advanced pancreatic cancer
- (2013) Davendra P. S. Sohal et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- A phase III concurrent chemoradiotherapy trial with cisplatin and paclitaxel or docetaxel or gemcitabine in unresectable non-small cell lung cancer: KASLC 0401
- (2013) In-Jae Oh et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Adjuvant sequential chemoradiation therapy in high-risk endometrial cancer: results of a prospective, multicenter phase-II study of the NOGGO (North-Eastern German Society of Gynaecological Oncology)
- (2013) A. Mustea et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Radioresistant Cancer Cells Can Be Conditioned to Enter Senescence by mTOR Inhibition
- (2013) H. Y. Nam et al. CANCER RESEARCH
- Cetuximab Attenuates Its Cytotoxic and Radiosensitizing Potential by Inducing Fibronectin Biosynthesis
- (2013) I. Eke et al. CANCER RESEARCH
- The Hallmarks of Aging
- (2013) Carlos López-Otín et al. CELL
- Immune-based mechanisms of cytotoxic chemotherapy: implications for the design of novel and rationale-based combined treatments against cancer
- (2013) L Bracci et al. CELL DEATH AND DIFFERENTIATION
- Radiotherapy alone versus radiochemotherapy in patients with stage IIIA adenocarcinoma (ADC) of the lung
- (2013) B. Jeremić et al. Clinical & Translational Oncology
- Radiotherapy of Human Sarcoma Promotes an Intratumoral Immune Effector Signature
- (2013) A. Sharma et al. CLINICAL CANCER RESEARCH
- Dose-Escalation Study of Three-Dimensional Conformal Thoracic Radiotherapy With Concurrent S-1 and Cisplatin for Inoperable Stage III Non–Small-Cell Lung Cancer
- (2013) Hideyuki Harada et al. Clinical Lung Cancer
- Inducers of immunogenic cancer cell death
- (2013) Aleksandra M. Dudek et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Improving outcomes in colorectal cancer: Where do we go from here?
- (2013) Eric Van Cutsem et al. EUROPEAN JOURNAL OF CANCER
- Postoperative external beam radiation therapy and concurrent cisplatin followed by carboplatin/paclitaxel for stage III (FIGO 2009) endometrial cancer
- (2013) Sarah A. Milgrom et al. GYNECOLOGIC ONCOLOGY
- Phase II trial of vaginal cuff brachytherapy followed by chemotherapy in early stage endometrial cancer patients with high-intermediate risk factors
- (2013) Lisa M. Landrum et al. GYNECOLOGIC ONCOLOGY
- Efficacy of90Yttrium-ibritumomab tiuxetan in relapsed/refractory extranodal marginal-zone lymphoma
- (2013) Anna Vanazzi et al. HEMATOLOGICAL ONCOLOGY
- Autophagy and Cellular Immune Responses
- (2013) Yuting Ma et al. IMMUNITY
- Mechanism of Action of Conventional and Targeted Anticancer Therapies: Reinstating Immunosurveillance
- (2013) Laurence Zitvogel et al. IMMUNITY
- Radio-responsive tumors exhibit greater intratumoral immune activity than nonresponsive tumors
- (2013) Scott A. Gerber et al. INTERNATIONAL JOURNAL OF CANCER
- A Phase I Study of Concurrent Weekly Carboplatin and Paclitaxel Combined With Intensity-Modulated Pelvic Radiotherapy as an Adjuvant Treatment for Early-Stage Cervical Cancer Patients With Positive Pelvic Lymph Nodes
- (2013) Seiji Mabuchi et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Preoperative Chemoradiation Therapy With Capecitabine/Oxaliplatin and Cetuximab in Rectal Cancer: Long-Term Results of a Prospective Phase 1/2 Study
- (2013) Emmanouil Fokas et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Neoadjuvant Chemoradiation for Distal Rectal Cancer: 5-Year Updated Results of a Randomized Phase 2 Study of Neoadjuvant Combined Modality Chemoradiation for Distal Rectal Cancer
- (2013) Mohammed Mohiuddin et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Phase 2 Study of Erlotinib Combined With Adjuvant Chemoradiation and Chemotherapy in Patients With Resectable Pancreatic Cancer
- (2013) Joseph M. Herman et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Administration of Concurrent Vaginal Brachytherapy During Chemotherapy for Treatment of Endometrial Cancer
- (2013) Himanshu Nagar et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Anal Carcinoma: Impact of TN Category of Disease on Survival, Disease Relapse, and Colostomy Failure in US Gastrointestinal Intergroup RTOG 98-11 Phase 3 Trial
- (2013) Leonard L. Gunderson et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Patterns of Failure in Advanced Stage Diffuse Large B-Cell Lymphoma Patients After Complete Response to R-CHOP Immunochemotherapy and the Emerging Role of Consolidative Radiation Therapy
- (2013) Zheng Shi et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Hypofractionated Image-Guided IMRT in Advanced Pancreatic Cancer With Simultaneous Integrated Boost to Infiltrated Vessels Concomitant With Capecitabine: A Phase I Study
- (2013) Paolo Passoni et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- RTOG 0417: Efficacy of Bevacizumab in Combination With Definitive Radiation Therapy and Cisplatin Chemotherapy in Untreated Patients With Locally Advanced Cervical Carcinoma
- (2013) Tracey Schefter et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Preoperative Radiation Therapy With Concurrent Capecitabine, Bevacizumab, and Erlotinib for Rectal Cancer: A Phase 1 Trial
- (2013) Prajnan Das et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Phase II Study of Concurrent Chemoradiotherapy at the Dose of 50.4 Gy with Elective Nodal Irradiation for Stage II-III Esophageal Carcinoma
- (2013) K. Kato et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Three-arm Phase III Trial Comparing Cisplatin Plus 5-FU (CF) Versus Docetaxel, Cisplatin Plus 5-FU (DCF) Versus Radiotherapy with CF (CF-RT) as Preoperative Therapy for Locally Advanced Esophageal Cancer (JCOG1109, NExT Study)
- (2013) Kenichi Nakamura et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Experience with combination of cetuximab plus intensity-modulated radiotherapy with or without chemotherapy for locoregionally advanced nasopharyngeal carcinoma
- (2013) Xiaoshuang Niu et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Postchemoradiation laparoscopic resection and intraoperative electron-beam radiation boost in locally advanced rectal cancer: long-term outcomes
- (2013) Felipe A. Calvo et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Leukemia inhibitory factor promotes nasopharyngeal carcinoma progression and radioresistance
- (2013) Shu-Chen Liu et al. JOURNAL OF CLINICAL INVESTIGATION
- Cellular senescence and the senescent secretory phenotype: therapeutic opportunities
- (2013) Tamara Tchkonia et al. JOURNAL OF CLINICAL INVESTIGATION
- Phase III Randomized Study of Rituximab/Carmustine, Etoposide, Cytarabine, and Melphalan (BEAM) Compared With Iodine-131 Tositumomab/BEAM With Autologous Hematopoietic Cell Transplantation for Relapsed Diffuse Large B-Cell Lymphoma: Results From the BMT CTN 0401 Trial
- (2013) Julie M. Vose et al. JOURNAL OF CLINICAL ONCOLOGY
- 90Yttrium-Ibritumomab Tiuxetan Consolidation of First Remission in Advanced-Stage Follicular Non-Hodgkin Lymphoma: Updated Results After a Median Follow-Up of 7.3 Years From the International, Randomized, Phase III First-Line Indolent Trial
- (2013) Franck Morschhauser et al. JOURNAL OF CLINICAL ONCOLOGY
- Rituximab, Methotrexate, Procarbazine, and Vincristine Followed by Consolidation Reduced-Dose Whole-Brain Radiotherapy and Cytarabine in Newly Diagnosed Primary CNS Lymphoma: Final Results and Long-Term Outcome
- (2013) Patrick G. Morris et al. JOURNAL OF CLINICAL ONCOLOGY
- Intensive Chemotherapy and Immunotherapy in Patients With Newly Diagnosed Primary CNS Lymphoma: CALGB 50202 (Alliance 50202)
- (2013) James L. Rubenstein et al. JOURNAL OF CLINICAL ONCOLOGY
- Fractionated90Y-Ibritumomab Tiuxetan Radioimmunotherapy As an Initial Therapy of Follicular Lymphoma: An International Phase II Study in Patients Requiring Treatment According to GELF/BNLI Criteria
- (2013) Tim M. Illidge et al. JOURNAL OF CLINICAL ONCOLOGY
- Transient regulatory T cell ablation deters oncogene-driven breast cancer and enhances radiotherapy
- (2013) Paula D. Bos et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Prognostic factors and treatment outcome after radiotherapy in cervical cancer patients with isolated para-aortic lymph node metastases
- (2013) Hyunsoo Jang et al. Journal of Gynecologic Oncology
- Radioimmunotherapy with 177Lu-DOTA-Rituximab: Final Results of a Phase I/II Study in 31 Patients with Relapsing Follicular, Mantle Cell, and Other Indolent B-Cell Lymphomas
- (2013) F. Forrer et al. JOURNAL OF NUCLEAR MEDICINE
- Randomized phase III trial of concurrent chemoradiotherapy vs accelerated hyperfractionation radiotherapy in locally advanced head and neck cancer
- (2013) Imjai Chitapanarux et al. JOURNAL OF RADIATION RESEARCH
- Phase I study of oral S-1 and concurrent radiotherapy in patients with head and neck cancer
- (2013) Kensei Nakata et al. JOURNAL OF RADIATION RESEARCH
- Clinical outcome of neoadjuvant chemoradiation therapy with oxaliplatin and capecitabine or 5-fluorouracil for locally advanced rectal cancer
- (2013) Jun-Yang Lu et al. JOURNAL OF SURGICAL ONCOLOGY
- Celecoxib plus chemoradiotherapy for locally advanced rectal cancer: A phase II TCOG study
- (2013) Ling-Wei Wang et al. JOURNAL OF SURGICAL ONCOLOGY
- Evaluation of capecitabine and oxaliplatin administered prior to and then concomitant to radiotherapy in high risk locally advanced rectal cancer
- (2013) Yuan-Hong Gao et al. JOURNAL OF SURGICAL ONCOLOGY
- A Phase II Study with Cetuximab and Radiation Therapy for Patients with Surgically Resectable Esophageal and GE Junction Carcinomas: Hoosier Oncology Group G05-92
- (2013) Carlos R. Becerra et al. Journal of Thoracic Oncology
- Transurethral surgery and twice-daily radiation plus paclitaxel-cisplatin or fluorouracil-cisplatin with selective bladder preservation and adjuvant chemotherapy for patients with muscle invasive bladder cancer (RTOG 0233): a randomised multicentre phase 2 trial
- (2013) Timur Mitin et al. LANCET ONCOLOGY
- Preference for subcutaneous or intravenous administration of trastuzumab in patients with HER2-positive early breast cancer (PrefHer): an open-label randomised study
- (2013) Xavier Pivot et al. LANCET ONCOLOGY
- Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trial
- (2013) Thomas Crosby et al. LANCET ONCOLOGY
- Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial
- (2013) Charles Butts et al. LANCET ONCOLOGY
- A multicenter phase II study of cetuximab in combination with chest radiotherapy and consolidation chemotherapy in patients with stage III non-small cell lung cancer
- (2013) S.S. Ramalingam et al. LUNG CANCER
- Randomized phase II trial of non-platinum induction or consolidation chemotherapy plus concomitant chemoradiation in stage III NSCLC patients: Mature results of the Spanish Lung Cancer Group 0008 study
- (2013) Pilar Garrido et al. LUNG CANCER
- The addition of amifostine to carboplatin and paclitaxel based chemoradiation in locally advanced non-small cell lung cancer: Long-term follow-up of Radiation Therapy Oncology Group (RTOG) randomized trial 9801
- (2013) Yaacov Richard Lawrence et al. LUNG CANCER
- Randomized phase II trial of uracil/tegafur and cisplatin versus vinorelbine and cisplatin with concurrent thoracic radiotherapy for locally advanced unresectable stage III non-small-cell lung cancer: NJLCG 0601
- (2013) Shunichi Sugawara et al. LUNG CANCER
- 10-year long-term survival (LTS) of induction chemotherapy with three cycles cisplatin/paclitaxel followed by concurrent chemoradiation cisplatin/etoposide/45Gy (1.5Gy bid) plus surgery in locally advanced non-small-cell lung cancer (NSCLC)—A multicenter phase-II trial (CISTAXOL)
- (2013) Wilfried Ernst Erich Eberhardt et al. LUNG CANCER
- Prospective phase II trial of neoadjuvant chemo-radiotherapy with Oxaliplatin and Capecitabine in locally advanced rectal cancer (XELOXART)
- (2013) Umberto Ricardi et al. MEDICAL ONCOLOGY
- Induction of intestinal stem cells by R-spondin 1 and Slit2 augments chemoradioprotection
- (2013) Wei-Jie Zhou et al. NATURE
- Phase I trial of capecitabine rapidly disintegrating tablets and concomitant radiation therapy in children with newly diagnosed brainstem gliomas and high-grade gliomas
- (2013) Lindsay B. Kilburn et al. NEURO-ONCOLOGY
- Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
- (2013) C. Parker et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Phase II Study of Preoperative Chemotherapy With Modified FOLFOX6 Followed by Surgery and Postoperative Chemoradiation in Patients With Localized Gastric Adenocarcinoma
- (2013) Shao-shui Chen et al. ONCOLOGY RESEARCH
- Postoperative Chemoradiotherapy Combined with Epirubicin-Based Triplet Chemotherapy for Locally Advanced Adenocarcinoma of the Stomach or Gastroesophageal Junction
- (2013) Guichao Li et al. PLoS One
- Phase II Study of Concurrent Capecitabine and External Beam Radiotherapy for Pain Control of Bone Metastases of Breast Cancer Origin
- (2013) Yulia Kundel et al. PLoS One
- Neoadjuvant oxaliplatin and 5-fluorouracil with concurrent radiotherapy in patients with locally advanced rectal cancer: a singleinstitution experience
- (2013) D. Greto et al. Radiologia Medica
- Immunomonitoring and prognostic relevance of neutrophils in clinical trials
- (2013) Frede Donskov SEMINARS IN CANCER BIOLOGY
- Preoperative chemoradiation with or without induction oxaliplatin plus 5-fluorouracil in locally advanced rectal cancer
- (2013) F.A. Calvo et al. STRAHLENTHERAPIE UND ONKOLOGIE
- Feasibility of 6-month maintenance cetuximab after adjuvant concurrent chemoradiation plus cetuximab in squamous cell carcinoma of the head and neck
- (2013) C. Matuschek et al. STRAHLENTHERAPIE UND ONKOLOGIE
- Concurrent hyperfractionated accelerated radiotherapy with 5-FU and once weekly cisplatin in locally advanced head and neck cancer
- (2013) V. Budach et al. STRAHLENTHERAPIE UND ONKOLOGIE
- Effect of concurrent chemotherapy and hyperthermia on outcome of preoperative radiotherapy of high-risk soft tissue sarcomas
- (2013) F. Eckert et al. STRAHLENTHERAPIE UND ONKOLOGIE
- Response of liver metastases to preoperative radiochemotherapy in patients with locally advanced rectal cancer and resectable synchronous liver metastases
- (2013) Gilles Manceau et al. SURGERY
- A novel, disruptive vaccination technology
- (2013) Karl-Josef Kallen et al. Human Vaccines & Immunotherapeutics
- Helical Tomotherapy for Inoperable Breast Cancer: A New Promising Tool
- (2013) Ciprian Chira et al. Biomed Research International
- Concurrent Radiotherapy and Ipilimumab Immunotherapy for Patients with Melanoma
- (2013) C. A. Barker et al. Cancer Immunology Research
- An Abscopal Response to Radiation and Ipilimumab in a Patient with Metastatic Non-Small Cell Lung Cancer
- (2013) E. B. Golden et al. Cancer Immunology Research
- Clinical response of advanced cancer patients to cellular immunotherapy and intensity-modulated radiation therapy
- (2013) Kenichiro Hasumi et al. OncoImmunology
- Exploiting the stress response to radiation to sensitize poorly immunogenic tumors to anti-CTLA-4 treatment
- (2013) Sandra Demaria et al. OncoImmunology
- Current trends of anticancer immunochemotherapy
- (2013) Erika Vacchelli et al. OncoImmunology
- Synchronous apoptosis in established tumors leads to the induction of adaptive immunity
- (2013) Jamie Honeychurch et al. OncoImmunology
- A new strategy to target regulatory T cells in solid tumors
- (2013) Audrey Thomas-Schoemann et al. OncoImmunology
- Myeloid derived suppressor cells
- (2013) Todd J. Waldron et al. OncoImmunology
- Immunomodulation of the tumor microenvironment by Toll-like receptor-3 (TLR3) ligands
- (2013) Valerie Chew et al. OncoImmunology
- The immunomodulatory effects of bevacizumab on systemic immunity in patients with metastatic melanoma
- (2013) Aaron S. Mansfield et al. OncoImmunology
- Following up tumor-specific regulatory T cells in cancer patients
- (2013) Laurence Zitvogel et al. OncoImmunology
- Radiation-induced tumor dormancy reflects an equilibrium between the proliferation and T lymphocyte-mediated death of malignant cells
- (2013) Hua Liang et al. OncoImmunology
- The Janus face of cyclophosphamide
- (2013) Giovanna Ziccheddu et al. OncoImmunology
- Inhibiting the inhibitors
- (2013) Domenico Mavilio et al. OncoImmunology
- Autophagy-dependent suppression of cancer immunogenicity and effector mechanisms of innate and adaptive immunity
- (2013) Abhishek D Garg et al. OncoImmunology
- Macrophages
- (2013) Sofia Edin et al. OncoImmunology
- Trial Watch
- (2013) Erika Vacchelli et al. OncoImmunology
- Trial Watch
- (2013) Erika Vacchelli et al. OncoImmunology
- Tumor-associated macrophages subvert T-cell function and correlate with reduced survival in clear cell renal cell carcinoma
- (2013) Stefanie Regine Dannenmann et al. OncoImmunology
- Immunogenic cell death in radiation therapy
- (2013) Lorenzo Galluzzi et al. OncoImmunology
- Trial Watch
- (2013) Erika Vacchelli et al. OncoImmunology
- TLR3 agonists improve the immunostimulatory potential of cetuximab against EGFR+head and neck cancer cells
- (2013) Chwee Ming Lim et al. OncoImmunology
- Trial watch
- (2013) Erika Vacchelli et al. OncoImmunology
- The interplay between regulatory T cells and metabolism in immune regulation
- (2013) Hu Zeng et al. OncoImmunology
- TIM3+FOXP3+regulatory T cells are tissue-specific promoters of T-cell dysfunction in cancer
- (2013) Kaori Sakuishi et al. OncoImmunology
- The immune checkpoint regulator PD-L1 is a specific target for naturally occurring CD4+T cells
- (2013) Shamaila Munir et al. OncoImmunology
- A Two-cohort Phase I Study of Weekly Oxaliplatin and Gemcitabine, Then Oxaliplatin, Gemcitabine, and Erlotinib During Radiotherapy for Unresectable Pancreatic Carcinoma
- (2012) Laura Raftery et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Yttrium-90 Microsphere-selective Internal Radiation Therapy With Chemotherapy (Chemo-SIRT) for Colorectal Cancer Liver Metastases
- (2012) Seza A. Gulec et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making
- (2012) H. J. Schmoll et al. ANNALS OF ONCOLOGY
- Immunogenic Cell Death in Cancer Therapy
- (2012) Guido Kroemer et al. Annual Review of Immunology
- Cancer treatment and survivorship statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Iodine-131 Rituximab Radioimmunotherapy with BEAM Conditioning and Autologous Stem Cell Transplant Salvage Therapy for Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma
- (2012) Paul C. Kruger et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Phase 1 Radioimmunotherapy Study with Lutetium 177–labeled Anti-Carbonic Anhydrase IX Monoclonal Antibody Girentuximab in Patients with Advanced Renal Cell Carcinoma
- (2012) Alexander B. Stillebroer et al. EUROPEAN UROLOGY
- A phase I study of S-1 with concurrent radiotherapy in elderly patients with locally advanced non-small cell lung cancer
- (2012) Yoshikazu Hasegawa et al. INVESTIGATIONAL NEW DRUGS
- Pre-operative chemoradiation followed by post-operative adjuvant therapy with tetrathiomolybdate, a novel copper chelator, for patients with resectable esophageal cancer
- (2012) Bryan J. Schneider et al. INVESTIGATIONAL NEW DRUGS
- Mitochondria and cell signalling
- (2012) Stephen W. G. Tait et al. JOURNAL OF CELL SCIENCE
- Ipilimumab in Combination With Paclitaxel and Carboplatin As First-Line Treatment in Stage IIIB/IV Non–Small-Cell Lung Cancer: Results From a Randomized, Double-Blind, Multicenter Phase II Study
- (2012) Thomas J. Lynch et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy of cetuximab in the treatment of squamous cell carcinoma
- (2012) Sophie Preneau et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Addition of Algenpantucel-L Immunotherapy to Standard Adjuvant Therapy for Pancreatic Cancer: a Phase 2 Study
- (2012) Jeffrey M. Hardacre et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Second Malignant Neoplasms and Cardiovascular Disease Following Radiotherapy
- (2012) Lois B. Travis et al. JNCI-Journal of the National Cancer Institute
- Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial
- (2012) Kim Margolin et al. LANCET ONCOLOGY
- Bortezomib may be safely combined with Y-90-ibritumomab tiuxetan in patients with relapsed/refractory follicular non-Hodgkin lymphoma: a phase I trial of combined induction therapy and bortezomib consolidation
- (2012) Rupali Roy et al. LEUKEMIA & LYMPHOMA
- Past, present and future of radiotherapy for the benefit of patients
- (2012) Juliette Thariat et al. Nature Reviews Clinical Oncology
- The secret ally: immunostimulation by anticancer drugs
- (2012) Lorenzo Galluzzi et al. NATURE REVIEWS DRUG DISCOVERY
- Mitochondria: master regulators of danger signalling
- (2012) Lorenzo Galluzzi et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Abscopal Effect in a Patient with Melanoma
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Advances in radiotherapy
- (2012) S. S. Ahmad et al. BMJ-British Medical Journal
- Combination of vaccine and immune checkpoint inhibitor is safe with encouraging clinical activity
- (2012) Ravi A Madan et al. OncoImmunology
- Dendritic cell inhibition correlates with survival of colorectal cancer patients on bevacizumab treatment
- (2012) Adriana J. Michielsen et al. OncoImmunology
- High expression of CD20+ lymphocytes in soft tissue sarcomas is a positive prognostic indicator
- (2012) Sveinung W. Sorbye et al. OncoImmunology
- TLR3/TICAM-1 signaling in tumor cell RIP3-dependent necroptosis
- (2012) Tsukasa Seya et al. OncoImmunology
- Abscopal but desirable
- (2012) Guido Kroemer et al. OncoImmunology
- Trial Watch
- (2012) Erika Vacchelli et al. OncoImmunology
- The emergence of phox-ER stress induced immunogenic apoptosis
- (2012) Abhishek D. Garg et al. OncoImmunology
- Radiotherapy supports protective tumor-specific immunity
- (2012) Anurag Gupta et al. OncoImmunology
- Trial watch
- (2012) Lorenzo Galluzzi et al. OncoImmunology
- A model for cancer-suppressive inflammation
- (2012) Ole Audun Werner Haabeth et al. OncoImmunology
- Trial watch
- (2012) Laura Senovilla et al. OncoImmunology
- Targeting PD-1/PD-L1 interactions for cancer immunotherapy
- (2012) Laurence Zitvogel et al. OncoImmunology
- Single-dose cyclophosphamide synergizes with immune responses to the renal cell cancer vaccine IMA901
- (2012) Steffen Walter et al. OncoImmunology
- Immunogenic tumor cell death induced by chemoradiotherapy in a clinical setting
- (2012) Koji Kono et al. OncoImmunology
- Angiogenesis and immunity: a bidirectional link potentially relevant for the monitoring of antiangiogenic therapy and the development of novel therapeutic combination with immunotherapy
- (2011) Eric Tartour et al. CANCER AND METASTASIS REVIEWS
- Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012
- (2011) L Galluzzi et al. CELL DEATH AND DIFFERENTIATION
- Mitigation of radiation-induced lung injury by genistein and EUK-207
- (2011) Javed Mahmood et al. INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
- Toll-like Receptor 5 Agonist Protects Mice From Dermatitis and Oral Mucositis Caused by Local Radiation: Implications for Head-and-Neck Cancer Radiotherapy
- (2011) Lyudmila G. Burdelya et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Palifermin Reduces Severe Mucositis in Definitive Chemoradiotherapy of Locally Advanced Head and Neck Cancer: A Randomized, Placebo-Controlled Study
- (2011) Quynh-Thu Le et al. JOURNAL OF CLINICAL ONCOLOGY
- Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registries
- (2011) Amy Berrington de Gonzalez et al. LANCET ONCOLOGY
- Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling
- (2011) Wim de Lau et al. NATURE
- Mitotic catastrophe: a mechanism for avoiding genomic instability
- (2011) Ilio Vitale et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
- Normalization of the Vasculature for Treatment of Cancer and Other Diseases
- (2011) Shom Goel et al. PHYSIOLOGICAL REVIEWS
- Autophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice
- (2011) M. Michaud et al. SCIENCE
- A mitochondria-targeted inhibitor of cytochrome c peroxidase mitigates radiation-induced death
- (2011) Jeffrey Atkinson et al. Nature Communications
- R-spondin 1 protects against inflammatory bone damage during murine arthritis by modulating the Wnt pathway
- (2010) Gerhard Krönke et al. ARTHRITIS AND RHEUMATISM
- Illicit survival of cancer cells during polyploidization and depolyploidization
- (2010) I Vitale et al. CELL DEATH AND DIFFERENTIATION
- Decreasing the Adverse Effects of Cancer Therapy: National Cancer Institute Guidance for the Clinical Development of Radiation Injury Mitigators
- (2010) B. Movsas et al. CLINICAL CANCER RESEARCH
- Use of Normal Tissue Complication Probability Models in the Clinic
- (2010) Lawrence B. Marks et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Molecular mechanisms of necroptosis: an ordered cellular explosion
- (2010) Peter Vandenabeele et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Mitochondria and cell death: outer membrane permeabilization and beyond
- (2010) Stephen W. G. Tait et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The role of apoptosis in radiation oncology
- (2009) Raymond E. Meyn et al. INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
- Sustained in vitro intestinal epithelial culture within a Wnt-dependent stem cell niche
- (2009) Akifumi Ootani et al. NATURE MEDICINE
- Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
- (2009) Eric Van Cutsem et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Mitochondria-Targeted Triphenylphosphonium-Conjugated Nitroxide Functions as a Radioprotector/Mitigator
- (2009) Jianfei Jiang et al. RADIATION RESEARCH
- Can we reduce the incidence of second primary malignancies occurring after radiotherapy? A critical review
- (2009) Maurice Tubiana RADIOTHERAPY AND ONCOLOGY
- Clinical biomarkers and imaging for radiotherapy-induced cell death
- (2008) Marcel Verheij CANCER AND METASTASIS REVIEWS
- Necroptosis: A Specialized Pathway of Programmed Necrosis
- (2008) Lorenzo Galluzzi et al. CELL
- Long-Term Results of Concomitant Boost Radiation Plus Concurrent Cisplatin for Advanced Head and Neck Carcinomas: A Phase II Trial of the Radiation Therapy Oncology Group (RTOG 99-14)
- (2008) Adam S. Garden et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Impact of Adding Concomitant Chemotherapy to Hyperfractionated Accelerated Radiotherapy for Advanced Head-and-Neck Squamous Cell Carcinoma
- (2008) Sandra Nuyts et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- American Society of Clinical Oncology 2008 Clinical Practice Guideline Update: Use of Chemotherapy and Radiation Therapy Protectants
- (2008) Martee L. Hensley et al. JOURNAL OF CLINICAL ONCOLOGY
- Head and neck cancer
- (2008) Athanassios Argiris et al. LANCET
- An Agonist of Toll-Like Receptor 5 Has Radioprotective Activity in Mouse and Primate Models
- (2008) L. G. Burdelya et al. SCIENCE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started